The North American Neuromodulation Society (NANS) hosts the NANS 2027 Annual Meeting, returning to Las Vegas, Nevada, from January 21 to January 24, 2027. Widely regarded as the premier gathering in the field of neuromodulation, the annual meeting convenes an international interdisciplinary audience comprising leading clinicians, neurosurgeons, pain specialists, neurologists, researchers, biomedical engineers, and commercial industry partners. Together, attendees examine groundbreaking scientific discoveries, clinical innovations, and advanced engineering technologies that continue to shape the trajectory of patient care and neuromodulatory therapeutics.
The scientific program at NANS 2027 is structured to offer deep insights into emerging technologies and evolving clinical paradigms. The congress features presentations across diverse neuromodulation modalities, covering areas such as spinal cord stimulation, deep brain stimulation, peripheral nerve stimulation, and targeted drug delivery systems. Accepted scientific abstracts will be showcased through dedicated podium oral presentations, conventional paper posters, and interactive ePosters, allowing investigators and clinicians to present original research findings and clinical trial outcomes. Attendees can explore basic science research, translational developments, and clinical applications aimed at addressing chronic pain syndromes, movement disorders, and other neurological conditions.
In addition to the formal scientific sessions, NANS 2027 serves as an essential nexus for networking and professional collaboration. Participants have the opportunity to engage with international thought leaders, exchange clinical expertise, establish research collaborations, and evaluate state-of-the-art medical devices and technological solutions presented by industry partners. Whether expanding foundational clinical knowledge, gaining updates on regulatory developments, or discovering cutting-edge solutions, the annual meeting offers a comprehensive venue to learn, grow, and lead within neuromodulation.